Global Botulinum Toxin Market Overview:
Botulinum toxin (BTX), a neurotoxic protein and muscle-relaxing medication that’s made from bacteria called Clostridium botulinum. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Growing healthcare infrastructure in the developing economies and research and development in the healthcare industry expected to drive the demand for Botulinum toxin market in the upcoming years. Some of the key players profiled in the study are Allergan Plc. (Ireland), Nestlé Skin Health (Galderma) (Switzerland), Merz Pharma GmbH & Co. KGaA (Germany), Daewoong Pharmaceutical (South Korea), Ipsen Pharma (France), Medytox Inc. (South Korea), US WorldMeds LLC (United States), Revance Therapeutics Inc. (United States) and Metabiologics, Inc. (United States).
On the basis of geography, the market of Botulinum Toxin has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End User, the sub-segment i.e. Hospitals will boost the Botulinum Toxin market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Surging Prevalence of Cervical Dystonia, Spasticity, Glabellar Lines and Crow’s Foot and Increase in the Use of Botulinum Toxin Type A
- Rapid Adoption of Minimally Invasive Treatment Globally
- Introduction of New and Improvised in Type B Products by Major Market Players
- High Cost of Botulinum Toxin
- Increasing Cases of Migraine and Surge in the Demand for Non-Surgical Therapeutic Procedure
- Rising Healthcare Expenditure in Developing Nations
- Stringent Government Regulations Regarding Drugs Approval
- Intense Competition among Key Market Players
Target Audience:Botulinum Toxin Manufacturers, Raw Material Suppliers, Product Suppliers/Distributors, End Users and Others
Major Objectives Focused through this Study To define, describe, and forecast the Global Botulinum Toxin market on the basis of product [Botulinum Toxin Type A, Botulinum Toxin Type B and Others] , application [Cosmetic Applications and Therapeutic Applications], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Botulinum Toxin market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Botulinum Toxin industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization: Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are .
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Botulinum Toxin market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.